Filtros de búsqueda

Lista de obras de

3 + 7 + FLT3 inhibitors: 1 + 1 ≠ 2.

artículo científico publicado en 2017

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial ⬇️

artículo científico publicado en 2015

A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets

artículo científico publicado en 2013

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

scientific article published on 18 January 2019

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with -mutated acute myeloid leukemia: CALGB 11001

article published in 2017

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

artículo científico publicado en 2017

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.

artículo científico publicado en 2008

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).

artículo científico publicado en 2013

Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors ⬇️

artículo científico publicado en 2013

Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

artículo científico publicado en 2015

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2017

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

artículo científico publicado en 2014

Acute myeloid leukemia, version 2.2013.

artículo científico publicado en 2013

Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) (Alliance C11001) ⬇️

artículo científico publicado en 2015

Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years

artículo científico publicado en 2020

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance) ⬇️

artículo científico publicado en 2012

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial

artículo científico publicado en 2019

Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study ⬇️

scholarly article

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

artículo científico publicado en 2019

Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission

artículo científico publicado en 2016

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

artículo científico publicado en 2010

Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey

artículo científico publicado en 2018

Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.

artículo científico publicado en 2012

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

artículo científico publicado en 2006

Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).

artículo científico publicado en 2016

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission ⬇️

artículo científico publicado en 2011

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients ⬇️

scholarly article

Clinical and functional significance of circular RNAs in cytogenetically normal AML

scientific article published on 01 January 2020

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21

artículo científico publicado en 2019

Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.

artículo científico publicado en 2016

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients

artículo científico publicado en 2013

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

artículo científico publicado en 2020

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance) ⬇️

artículo científico publicado en 2013

Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations

artículo científico publicado en 2020

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically

artículo científico publicado en 2019

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions ⬇️

scholarly article

Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial

artículo científico publicado en 2009

Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation ⬇️

scholarly article

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.

artículo científico publicado en 2017

Differences In Perceptions Of Disease and Treatment Effectiveness and Adherence Between Physicians and Patients With Myelodysplastic Syndromes (MDS) ⬇️

scholarly article

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

artículo científico publicado en 2004

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) ⬇️

artículo científico publicado en 2013

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia

artículo científico publicado en 2017

Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes

artículo científico publicado en 2014

Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.

artículo científico publicado en 2012

Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax

scientific article published in 2022

End points to establish the efficacy of new agents in the treatment of acute leukemia

artículo científico publicado en 2006

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score

artículo científico publicado en 2013

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

artículo científico publicado en 2019

Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) ⬇️

artículo científico publicado en 2018

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

artículo científico publicado en 2014

FLT3 Splice Variant (FLT3Va) As a Potential Immunotherapeutic Target in Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2016

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

artículo científico publicado en 2010

Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of U.S. Intergroup Trial C10403 ⬇️

scholarly article

Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.

artículo científico publicado en 2008

Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B.

artículo científico publicado en 2006

Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?

artículo científico publicado en 2020

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

artículo científico publicado en 2006

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

artículo científico publicado en 2013

Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

artículo científico publicado en 2019

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA

artículo científico publicado en 2018

Genomic and Proteomic Analysis of Primary Chemoresistance and Induction Failure in Acute Myeloid Leukemia ⬇️

scholarly article

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

artículo científico publicado en 2019

Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia

artículo científico publicado en 2016

Geriatric Assessment Variables Add Prognostic Value to the International Prognostic Scoring System ⬇️

artículo científico publicado en 2012

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance)

scientific article published on 24 October 2019

Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes

artículo científico publicado en 2013

Health care utilization and end-of-life care for older patients with acute myeloid leukemia

artículo científico publicado en 2015

High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.

artículo científico publicado en 2010

HighNPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

article

How I treat mixed-phenotype acute leukemia.

artículo científico publicado en 2015

IDH1 Splicing Alterations in Patients with AML and Their Relationship to Blood 2HG Levels ⬇️

artículo científico publicado en 2014

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

artículo científico publicado en 2002

Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

artículo científico publicado en 2020

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes

artículo científico publicado en 2018

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

artículo científico publicado en 2018

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

artículo científico publicado en 2016

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes

artículo científico publicado en 2016

Initial Results Of a Phase II Trial Of Sorafenib Plus Standard Induction In Older Adults With Mutant FLT3 Acute Myeloid Leukemia (AML) (Alliance trial C11001) ⬇️

artículo científico publicado en 2013

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

artículo científico publicado en 2002

Ivosidenib (AG-120) Induced Durable Remissions and Transfusion Independence in Patients with IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Results from a Phase 1 Dose Escalation and Expansion Study ⬇️

artículo científico publicado en 2018

Ivosidenib (AG-120) Induced Durable Remissions and Transfusion Independence in Patients with IDH1-Mutant Untreated AML: Results from a Phase 1 Dose Escalation and Expansion Study ⬇️

artículo científico publicado en 2018

Ivosidenib (AG-120) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome: Updated Enrollment of a Phase 1 Dose Escalation and Expansion Study ⬇️

artículo científico publicado en 2019

Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to MRD-Negative Complete Remissions ⬇️

artículo científico publicado en 2018

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

artículo científico publicado en 2020

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Lenalidomide in AML: del(5q) or who?

scientific article published on 01 July 2011

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

artículo científico publicado en 2003

Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance ⬇️

scholarly article

Low Clinical Trial Accrual of Patients With Myelodysplastic Syndromes: Causes and Potential Solutions

artículo científico publicado en 2018

Low Efficacy and High Mortality Associated with Clofarabine Treatment of Patients with Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes ⬇️

scholarly article

Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2014

Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes

artículo científico publicado en 2020

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.

artículo científico publicado en 2008

MEN1 mutations mediate clinical resistance to menin inhibition

scientific article published on 15 March 2023

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

artículo científico publicado en 2020

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

artículo científico publicado en 2017

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

artículo científico publicado en 2018

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

artículo científico publicado en 2018

Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality

artículo científico publicado en 2016

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A

artículo científico publicado en 2020

Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia

scientific article published on 14 August 2019

Myelodysplastic syndromes

artículo científico publicado en 2008

Myelodysplastic syndromes clinical practice guidelines in oncology

Myelodysplastic syndromes, version 2.2015

artículo científico publicado en 2015

Myelodysplastic syndromes: clinical practice guidelines in oncology

artículo científico publicado en 2013

NCCN Clinical Practice Guidelines Acute myeloid leukemia

artículo científico publicado en 2012

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes

artículo científico publicado en 2011

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome

NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML

artículo científico publicado en 2014

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

artículo científico publicado en 2007

Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults

artículo científico publicado en 2015

North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia ⬇️

artículo científico publicado en 2015

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches

artículo científico publicado en 2019

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study

artículo científico publicado en 2004

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit ⬇️

artículo científico publicado en 2015

Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission

scientific article published on 12 July 2019

Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

scientific article published on 23 August 2018

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes ⬇️

scholarly article

Patients over Age 40 with Ph-Negative Acute Lymphoblastic Leukemia Do Not Benefit from Allogeneic Transplant in First Remission. Retrospective Analysis from a Large Tertiary Center ⬇️

artículo científico publicado en 2015

Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey

artículo científico publicado en 2011

Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia

artículo científico publicado en 2016

Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia

artículo científico

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

scientific article published on 15 June 2013

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O

article

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria ⬇️

artículo científico publicado en 2018

Potentially Avoidable Hospitalizations in Older Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2015

Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis

artículo científico publicado en 2016

Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes

artículo científico publicado en 2010

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

artículo científico publicado en 2002

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

artículo científico publicado en 2006

Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

artículo científico publicado en 2019

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia

artículo científico

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.

artículo científico publicado en 2014

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia

artículo científico publicado en 2012

Prospective Cohort Study of Geriatric Assessment in Older Patients with Acute Myeloid Leukemia ⬇️

artículo científico publicado en 2012

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML) ⬇️

artículo científico publicado en 2018

Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy

artículo científico publicado en 2019

Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples

artículo científico publicado en 2006

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

artículo científico publicado en 2017

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

artículo científico publicado en 2002

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

scholarly article published 26 December 2018

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

artículo científico publicado en 2020

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials

artículo científico publicado en 2015

Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia

artículo científico publicado en 2013

Self-reported sleep disturbance and survival in myelodysplastic syndromes

artículo científico publicado en 2017

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Survival after Hematopoietic Stem Cell Transplantation in an Older, Fit Cohort of Patients with Advanced Myelodysplastic Syndromes: The MDS-TAO Study ⬇️

artículo científico publicado en 2018

Systematic STAT3 Mutation Testing Identifies Patients with Unsuspected T-Cell Large Granular Lymphocytic Leukemia ⬇️

artículo científico publicado en 2016

Systematic sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia

scientific article published on 13 September 2017

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

artículo científico publicado en 2014

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

scientific article published on 11 January 2019

Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

scholarly article published 10 July 2018

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts) ⬇️

artículo científico publicado en 2012

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

Thrombosis in Myeloproliferative Neoplasms Is Linked to Increased Neutrophil Extracellular Trap (NET) Formation ⬇️

scholarly article

Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).

artículo científico publicado en 2009

Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a Large Web-Based Survey ⬇️

scholarly article

Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey

artículo científico publicado en 2020

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda